Utility of (18)fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma

BACKGROUND: For patients with peripheral T-cell lymphoma (PTCL), the value of (18)fluoro-deoxyglucose positron emission tomography (FDG-PET) scans for assessing prognosis and response to treatment remains unclear. The utility of FDG-PET, in addition to conventional radiology, was examined as a plann...

Descripción completa

Detalles Bibliográficos
Autores principales: Horwitz, S., Coiffier, B., Foss, F., Prince, H. M., Sokol, L., Greenwood, M., Caballero, D., Morschhauser, F., Pinter-Brown, L., Iyer, S. P., Shustov, A., Nichols, J., Balser, J., Balser, B., Pro, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374388/
https://www.ncbi.nlm.nih.gov/pubmed/25605745
http://dx.doi.org/10.1093/annonc/mdv010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374388/
https://www.ncbi.nlm.nih.gov/pubmed/25605745
http://dx.doi.org/10.1093/annonc/mdv010

Ejemplares similares